Shares of Compugen (NASDAQ: CGEN) were jumping 7.9% as of 11:03 a.m. EDT on Thursday. The solid gain came after the drugmaker provided its first-quarter update before the market opened.
Today's solid uptick for the biotech stock likely had little to do with Compugen's Q1 financial results. The company didn't generate any revenue in the first quarter. Its net loss of $0.12 per share was a little better than what analysts expected, but that wasn't enough to fire up investors.
Image source: Getty Images.
For further details see:
Why Compugen Stock Is Jumping Today